Bioactive glass S53P4 in frontal sinus obliteration: A long-term clinical experience

Head and Neck

Volumn 28, Issue 9, 2006, Pages 834-841

  Peltola, Matti ^a   Aitasalo, Kalle ^a   Suonpää, Jouko ^a   Varpula, Matti ^a   Yli Urpo, Antti ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Bag; Frontal sinus obliteration; Long term

Indexed keywords

BIOACTIVE GLASS; CEFUROXIME; FIBRIN GLUE; GLASS; GLASS IONOMER; HYDROXYAPATITE; METHACRYLIC ACID METHYL ESTER; POLITEF; PROPLAST; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BONE REMODELING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; ETHMOIDECTOMY; FEMALE; FOLLOW UP; FRONTAL SINUS OBLITERATION; FRONTAL SINUSITIS; HAEMOPHILUS INFLUENZAE; HEALING; HISTOPATHOLOGY; HUMAN; INFRARED SPECTROSCOPY; MALE; NOSE SEPTUM RECONSTRUCTION; OSSIFICATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; FRONTAL BONE; FRONTAL SINUS; FRONTAL SINUSITIS; GLASS; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748270711     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20436     Document Type: Article

References (43)

1. Schaefer SD, Close LG. Endoscopic management of frontal sinus disease. Laryngoscope 1990;100:155-160.
2. Close LG, Leach JL, Lee NK, Manning SC. Endoscopic resection of the intranasal frontal sinus floor. Ann Otol Rhinol Laryngol 1994;103:952-958.
3. Gross CW, Gross WE, Becker DG. Modified transnasal endoscopic Lothrop procedure: frontal drill out. Opin Tech Otolaryngol Head Neck Surg 1995;6:193-200.
4. Har-El G, Lucente FE. Endoscopic intranasal frontal sinusotomy. Laryngoscope 1995;105:440-443.
5. Amble FR, Kern EB, Neel HB, Facer GW, McDonald TJ, Czaja JM. Nasofrontal duct reconstruction with silicone rubber sheeting for inflammatory frontal sinus disease: analysis of 164 cases. Laryngoscope 1996;106:809-815.
6. Metson R, Glicklich RE. Clinical outcome of endoscopic surgery for frontal sinusitis. Arch Otolaryngol Head Neck Surg 1998;124:1090-1096.
7. Weber R, Draf W, Kahle G, Kind M. Obliteration of the frontal sinus-state of the art and reflections on new materials. Rhinology 1999;37:1-15.
8. Jacobs JB. Osteoplastic flap with obliteration. Is this an ideal procedure for chronic frontal sinusitis? Arch Otolaryngol Head Neck Surg 2000;126:100.
9. Goodale RL. The radical obliterative frontal sinus obliteration. Ann Otol 1955;64:470-486.
10. Goodale RL, Montgomery WW. Anterior osteoplastic frontal sinus operation. Five years experience. Ann Otol Rhinol Laryngol 1961;70:860-880.
11. Calcaterra TC, Strahan RW Osteoplastic flap technique for disease of the frontal sinus. Surg Gynecol Obstet 1971;132:505-510.
12. Bosley WR. Osteoplastic obliteration of the frontal sinuses: a review of 100 patients. Laryngoscope 1972;82: 1463-1476.
13. Hardy JM, Montgomery WW. Osteoplastic frontal sinusotomy: an analysis of 250 operations. Ann Otol Rhinol Laryngol 1976;85:523-532.
14. Middleton WG, Briant DR, Fenton RS. Frontal sinusitis-a 10 year experience. J Otolaryngol 1985;14:197-200.
15. Catalano PJ, Lawson W, Som P, Biller HF. Radiographic evaluation and diagnosis of the failed frontal osteoplastic flap with fat obliteration. Otolaryngol Head Neck Surg 1991;104:225-234.
16. Schenck NL. Frontal sinus disease III. Experimental and clinical factors in failure of the frontal osteoplastic operation. Laryngoscope 1975;85:76-92.
17. Mann W, Riechelmann H, Gilsbach J. The state of the frontal sinus after craniotomy. Acta Neurochir 1989;100: 101-103.
18. Eppley BL. Alloplastic implantation. Plast Reconstr Surg 1999;104:1761-1783.
19. Aho AJ, Hirn M, Aro HT, Heikkilä JT, Meurman O. Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku bone bank 1972-1995. Acta Orthop Scand 1998;69:559-565.
20. Sailer HF, Grätz KW, Kalavrezos ND. Frontal sinus fractures: principles of treatment and long-term results after sinus obliteration with the use of lyophilized cartilage. J Craniomaxillofac Surg 1998;26:235-242.
21. Beeson WH. Plaster of Paris as an alloplastic implant in the frontal sinus. Arch Otolaryngol 1981;107:664-669.
22. Snyderman CH, Scioscia K, Carrau RL, Weissman JL. Hydroxyapatite: an alternative method for frontal sinus obliteration. Otolaryngol Clin North Am 2001;34:179-191.
23. Cole I, Dan N, Anker A. Bone replacement in head and neck surgery: a biocompatible alternative. Aust NZ J Surg 1996;66:469-472.
24. Janeke JB, Komorn RM, Cohn AM. Proplast in cavity obliteration and soft tissue augmentation. Arch Otolaryngol 1974;100:24-27.
25. Hench LL, Andersson OH. Bioactive glasses. Bioceramics 1993;1:41-62.
26. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981;15:805-817.
27. Gross U, Strunz V. The interface of various glasses and glass-ceramics with bony implantation bed. J Biomed Mater Res 1985;19:251-271.
28. Peltola M, Suopää J, Aitasalo K, Varpula M, Yli-Urpo A, Happonen R-P. Obliteration of frontal sinus cavity with bioactive glass. Head Neck 1998;20:315-319.
29. Peltola MJ, Suonpää JTK, Andersson OH, et al. In vitro model for frontal sinus obliteration with bioactive glass S53P4. J Biomed Mater Res Appl Biomater 2000;53:161-166.
30. Peltola MJ, Suonää JTK, Määtänen HS, et al. Clinical follow-up method for frontal sinus obliteration with bioactive glass S53P4. J Biomed Mater Res Appl Biomater 2001;58:54-60.
31. Peltola MJ, Aitasalo KMJ, Suonpää JTK, Yli-Urpo A, Laippala PJ. In vivo model for frontal sinus and calvarial bone defect obliteration with bioactive glass S53P4 and hydroxyapatite. J Biomed Mater Res Appl Biomater 2001;58:261-269.
32. Peltola MJ, Aitasalo KMJ, Suonpää JTK, Yli-Urpo A, Laippala PJ. Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study. J Biomed Mater Res Appl Biomater 2003; 66B:364-372.
33. Cancian DC, Hochuli-Vieira E, Marcantonio RA, Marcantonio E Jr. Use of Biogran and Calcitite in bone defects: histologic studies in monkeys (Cebus apella). Int J Oral Maxillofac Implants 1999;14:859-864.
34. Cancian DC, Hochuli-Vieira E, Marcantonio RA, Garcia R Jr. Utilization of autogenous bone, bioactive glasses and calcium phosphate cement in surgical mandibular bone defects in Cebus apella monkeys. Int J Oral Maxillofac Implants 2004;1:73-79.
35. Stoor P, Söderling E, Salonen JI. Antibacterial effects of bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998;56:161-165.
36. Stoor P, Söderling E, Andersson ÖH, Yli-Urpo A. Interactions between frontal sinus-associated pathogen Haemophilus influenzae and bioactive glass. Bioceramics 1995;8:253-258.
37. Wegener OH. Whole computerized tomography. Schering AG Oraniendruck GmbH: Berlin, 1983.
38. Aitasalo K, Peltola M, Suonpää J, et al. Obliteration of frontal sinuses with bioactive glass after chronic suppurative sinusitis. One year follow-up. Bioceramics 1994;7:409-414.
39. Wigand ME, Hosemann WG. Endoscopic surgery for frontal sinusitis and its complications. Am J Rhinol 1991; 5:85-89.
40. Stankiewitz JA, Wachter B. The endoscopic modified Lothrop procedure for salvage of chronic frontal sinusitis after osteoplastic flap failure. Otolaryngol Head Neck Surg 2003;6:678-683.
41. Montgomery WW, van Orman P. The inhibitory effect of adipose tissue on osteogenesis. Ann Otol 1967;76:988-997.
42. Stoor P, Grenman R. Bioactive glass and turbinate flaps in the repair of nasal septal perforations. Ann Otol Rhinol Laryngol 2004;8:655-661.
43. Schlosser RJ, London SD, Gwaltney JM Jr, Gross CW. Microbiology of chronic frontal sinusitis. Laryngoscope 2001;8:1330-1332.